NCT05325164View on ClinicalTrials.gov

Methadone for 'Adenocarcinopathic' Pain Treatment

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

September 30, 2023

Conditions
Cancer PainAdenocarcinoma
Interventions
DRUG

Methadone

Methadone

DRUG

Morphine

Morphine

Sponsors
All Listed Sponsors
collaborator

Bruyère Health Research Institute.

OTHER

collaborator

The Ottawa Hospital

OTHER

lead

Ottawa Hospital Research Institute

OTHER